Home » Regulatory » USFDA concludes inspection at Zydus Life's SEZ II Ahmedabad plant with 1 observation
Regulatory

USFDA concludes inspection at Zydus Life's SEZ II Ahmedabad plant with 1 observation

There were no data integrity related observations

  • By IPP Bureau | September 29, 2026

Zydus informed that the USFDA conducted cGMP inspection for the company’s manufacturing plant at SEZ II, Ahmedabad. The inspection was conducted from 21st to 28th September 2026. 

The inspection closed with one observation. There were no data integrity related observations. The company will closely work with the USFDA to address the observation expeditiously.

Upcoming E-conference

Other Related stories

EU moves closer to approving breakthrough equine drug to combat laminitis risk
Bayer gets FDA nod for Sunharbo, world's first FXIa inhibitor to prevent recurrent stroke
Alembic Pharma wins USFDA final approval for generic OTC Olopatadine eye drops
View More

Interviews

Collaborat
Collaborative models are practical way to build capability in biologics: Manoj Kumar Panicker, Cytiva and Dr. Sanjib Banerjee, Veeda Lifesciences
We positio
We position ourselves as US-led CRO with India-based delivery: Dr. Avi Kulkarni, CEO, InoRx
Nanotech h
Nanotech has potential to solve fundamental problems of dermatology: Dr. Gabriel Serrano, Founder, Sesderma
View More

Appointments

Centrix Pharma Solutions appoints pharma veteran Nathalie Huther to drive international growth
Centrix Pharma Solutions appoints pharma veteran Nathalie Huther to drive international growth
Glenmark Pharmaceuticals elevates Namita Shah to Sr. VP – Global Portfolio
Glenmark Pharmaceuticals elevates Namita Shah to Sr. VP – Global Portfolio
Zydus appoints Christoph Stoller as President and Business Unit Head, International Markets Business
Zydus appoints Christoph Stoller as President and Business Unit Head, International Markets Business
View More

Startup

Pune health-tech startup clinics on cloud raises $12.5 million as it sets sights on global expansion
Pune health-tech startup clinics on cloud raises $12.5 million as it sets sights on global expansion
StandardX raises £10m to build isotope refinery for cancer care and fusion
StandardX raises £10m to build isotope refinery for cancer care and fusion
C-CAMP National Bio Entrepreneurship competition 2026 recognises 15 startups and four student teams
C-CAMP National Bio Entrepreneurship competition 2026 recognises 15 startups and four student teams
View More

Digitization

Boehringer Ingelheim & Microsoft join forces to explore AI-powered digital patient twins
Boehringer Ingelheim & Microsoft join forces to explore AI-powered digital patient twins
Merck teams up with NVIDIA and Microsoft to build AI-powered support for rare tumor patients
Merck teams up with NVIDIA and Microsoft to build AI-powered support for rare tumor patients
AstraZeneca and Oracle join forces to use AI to accelerate clinical trials, early diagnosis
AstraZeneca and Oracle join forces to use AI to accelerate clinical trials, early diagnosis
View More

Latest Stories

IIT Kanpur scientists uncover molecular switch that shuts down insulin production in minutes

Moderna charts next growth phase as it bets on mRNA innovation, cancer treatments & AI

EU moves closer to approving breakthrough equine drug to combat laminitis risk

Roche begins new Alzheimer’s drug trial

Bristol Myers Squibb merges R&D divisions, names Cristian Massacesi head

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Opinion
Scientific credibility key to next phase of India's nutraceutical growth: Dr. Saurabh Arora, MD, Auriga Research
Scientific credibility key to next phase of India's nutraceutical growth: Dr. Saurabh Arora, MD, Auriga Research
AI moves from promise to practical impact in public health: Dr. Vikram Niranjan, University of Limerick
AI moves from promise to practical impact in public health: Dr. Vikram Niranjan, University of Limerick

Interviews
Collaborative models are practical way to build capability in biologics: Manoj Kumar Panicker, Cytiva and Dr. Sanjib Banerjee, Veeda Lifesciences
Collaborative models are practical way to build capability in biologics: Manoj Kumar Panicker, Cytiva and Dr. Sanjib Banerjee, Veeda Lifesciences
(L-R) Manoj Kumar Panicker, General Manager, South Asia, Cytiva and Dr. Sanjib Banerjee, Chief Operating Officer (Biopharma Services), Veeda Lifesciences.
We position ourselves as US-led CRO with India-based delivery: Dr. Avi Kulkarni, CEO, InoRx
We position ourselves as US-led CRO with India-based delivery: Dr. Avi Kulkarni, CEO, InoRx
Dr. Avi Kulkarni Chief Executive Officer, InoRx
Nanotech has potential to solve fundamental problems of dermatology: Dr. Gabriel Serrano, Founder, Sesderma
Nanotech has potential to solve fundamental problems of dermatology: Dr. Gabriel Serrano, Founder, Sesderma
Dr. Gabriel Serrano Founder, Sesderma

Packaging
Sanner commences manufacturing critical injection-molded components in USA
Sanner commences manufacturing critical injection-molded components in USA
UFlex introduces FSSAI compliant single-pellet solution for food packaging
UFlex introduces FSSAI compliant single-pellet solution for food packaging
Evertis selects Honeywell Aclar technology to enhance pharmaceutical packaging
Evertis selects Honeywell Aclar technology to enhance pharmaceutical packaging